FDA InspectionEmergent BioSolutions Canada Inc.
Emergent BioSolutions Canada Inc. – FDA Inspection, Aug 27, 2025
Record Details
This FDA Inspection record concerns Emergent BioSolutions Canada Inc., with an inspection on August 27, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
ID · 038d7346-96ca-4728-bce2-72acf2e4ad50
Inspection Facts
- Inspection number
- 1280431
- FDA center
- Human Drugs
Other FDA inspections of Emergent BioSolutions Canada Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| May 12, 2026 | Not classified | Office of Inspections and Investigations | Blood and Blood Products |
| September 13, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 16, 2017 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 3, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 18, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Comes with the profile
KRA (KeyPedia Risk Analysis)
How likely the FDA is to take enforcement action in the next 12 months.
Example18-month trend
Form 483 · August 27, 2025
What you get
A document
One file.
- One FDA document, such as a Form 483
- Yours for life in your Library
- Each has its own price
The profile
All the documents, plus intelligence about the company.
- Every Emergent BioSolutions Canada Inc. document on file
- The KRA score, which a single document does not include
- Observations and inspection history
Access
This, for every company on KeyPedia.
- Combine profiles in one search
- Search across any modality: products, industry types, drugs, devices and recalls
- Track everything as it changes
- Other agencies too, such as EMA, Health Canada and UK MHRA